Get Your Lost Erection Back with Sildenafil Citrate 100mg

Erectile dysfunction (ED) is a sick and naughty male sexual dysfunction to have.  Because of this condition, it inhibits you from having successful intercourse with your female partner.  This is because without an erection, vaginal penetration is not possible.  Fortunately, although only temporary, you can get your erection back using sildenafil citrate 100mg.  Sildenafil citrate 100mg is very effective in providing you the erection you lost due to erectile dysfunction as it is the generic alternative of Viagra, the most popular and highly sought after ED treatment drug.

Sildenafil citrate 100mg is classified as a PDE5 inhibitor drug because it follows the same mechanism of action of drugs belonging to that class.  What PDE5 inhibitor drugs do is that it selectively focuses on the smooth muscles lining the penis.  This smooth muscle relaxes when you are sexually stimulated to allow blood to enter the cavities within the penis so an erection can be achieved.  Once you are no longer sexually aroused, the smooth muscles then contracts back to squeeze the blood out of the penis so the penis becomes limp again.  This is actually what is great about PDE5 inhibitor drugs like sildenafil citrate 100mg because they provide you with a normal-like erection function. Read more…

Getting drug addiction treatment on track

Implants may trump liquid and pills

Methadone has helped countless people hooked on heroin and prescription pain relievers wean themselves off for over 40 years. A methadone alternative may soon outshine the well-known withdrawal aid in some important ways.

Buprenorphine hydrochloride, a semi-synthetic opioid compound used for pain control and detoxification, has been available in pill form for two years. But its downside includes diverting the tablets for sale on the streets and crushing and liquefying them into an injectable - and therefore more potent -- form.

A recent study published in the Journal of the American Medical Association (http://jama.ama-assn.org/cgi/content/short/304/14/1576) shows promise for a buprenorphine implant, called Probuphine by its California makers, Titan Pharmaceuticals.

One hundred and sixty-three opioid-dependent adults (18-65 years of age) received either four 3-cm long (a centimeter shy of the width of a ping-pong ball), ethylene vinyl acetate and buprenorphine implants, or 4 dummy rods for 6 months. The 108 participants with the real deal received 80 mg per implant. All the subjects were given drug counselling, and urine samples were taken to detect illicit drug use.

If anyone felt the slow-release dose from the implants did not combat their cravings sufficiently, they could request sublingual tablets. Over the first 16 weeks, about 60% of the buprenorphine group requested extra doses, while over 90% of the placebo-implanted group did. Urine samples tested negative for illicit opioids more often in the buprenorphine implant group than the placebo group (approximately 40% vs 28%) over the same timeframe. And more of the buprenorphine group opted to stay in the study for the full 24 weeks (66% vs 31%).

Cravings and other withdrawal symptoms were generally reduced in the treatment group, although there were minor adverse reactions reported, i.e. discomfort at the implant site, in both groups.

Considering that Canada ranks almost as high as Germany and the U.S. for prescription opioid use, a six-month implant may be well worth the trouble - as long as it doesn’t dissuade regular visits to the clinic for counselling.
Milena Katz